Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks bounce back after recent sell-off

Tue, 28th May 2013 11:20

UK markets were registering impressive gains on Tuesday morning with hopes of continued monetary easing in the Eurozone lifting sentiment as stocks bounced back following last week's sharp sell-off.After reaching a 13-year high on Wednesday, the FTSE 100 dropped sharply in the latter part of last week - losing nearly 3.0% in just two days - on fears of a scaling back of stimulus measures from the US Federal Reserve as well as some gloomy economic data from China.However with UK and US markets closed for national holidays on Monday, traders were looking to play catch up after missing out on the previous day's rally. Helping the bullish mood today were comments from European Central Bank (ECB) board member Peter Praet who said that the bank could still cut interest rates if needed to support the economy. In recent interviews, Praet said that "even after cutting the cost of money to a record low of 0.50%, the ECB signalled that the possibility of further easing was not exhausted".Market Analyst Craig Erlam from Alpari said: "Investor sentiment is on the rise in Europe this morning, with stock indices following in the footsteps of their Asian counterparts over night, which recovered early losses to end the session higher." Tuesday's session was the first positive day on Tokyo's Nikkei index since it dropped by 7.3% on Thursday."Now that the dust is beginning to settle, we could be seeing traders take advantage of the dip in the market to buy on the cheap. Given that the Bank of Japan's massive bond buying programme is only just getting under way, I think this will be the case," Erlam said.The economic data calendar was on the light side on Tuesday morning in Europe, though eyes will be fixed on consumer confidence and home-price figures in the States due out this afternoon.FTSE 100: TUI Travel, pharmas and banks provide a liftTour operator TUI Travel was among the best performers this morning, rising in sympathy with French peer Club Mediterranee after its shareholders Fosun International and Axa Private Equity joined forces to make a €540m bid for the firm.Drugs giant AstraZeneca higher after saying that it will continue to "vigorously" defend the intellectual property rights protecting its asthma medicine Pulmicort Respules. The company is appealing against a US court ruling that the patent protecting Pulmicort from rival drugs in the US is invalid. Sector peers Shire and GlaxoSmithKline were also in demand early on, with the latter being boosted by an upgrade by Deutsche Bank to 'buy'.Financial stocks were also performing well as markets on the whole rebounded from last week's sell-off. HSBC, Barclays and Standard Chartered were in positive territory, joined by part-nationalised lenders RBS and Lloyds which were both shrugging off downgrades by Citigroup today.Wood Group was also higher on news that its PSN business will continue to provide duty holder and asset management services to the Hummingbird Spirit floating storage offloading production vessel, under a new contract extension worth $87m from Teekay. Positive comments from Bank of America Merrill Lynch were helping share prices of a number of retailers this morning after the broker raised its target prices for Sainsbury, Marks & Spencer and Tesco.FTSE 250: Victrex jumps after first-half reportPolymer manufacturer Victrex was a high riser on the second-tier index after increasing its interim dividend by 15% despite a slight fall in profits. The company however still managed to beat profit before tax forecasts by 2.0% in the first half.Soft drinks maker AG Barr was also up as it managed to increase revenues by 2.4% in the first quarter in spite of the dismal weather.Mining firm Kazakhmys was heading the other way after announcing that it has sold its long-held German copper products unit MKM for €42m. "MKM is an excellent business, but did not fit with our geographic and strategic focus as a natural resources company in Central Asia," the company said.FTSE 100 - RisersPetrofac Ltd. (PFC) 1,391.00p +3.81%Barclays (BARC) 328.95p +3.77%TUI Travel (TT.) 371.50p +3.63%CRH (CRH) 1,438.00p +3.45%Weir Group (WEIR) 2,373.00p +3.40%Melrose Industries (MRO) 263.70p +3.33%GKN (GKN) 305.90p +3.21%International Consolidated Airlines Group SA (CDI) (IAG) 281.60p +3.15%Babcock International Group (BAB) 1,202.00p +3.09%AstraZeneca (AZN) 3,534.00p +3.09%FTSE 100 - FallersEurasian Natural Resources Corp. (ENRC) 249.00p -2.28%Randgold Resources Ltd. (RRS) 4,921.00p -1.34%Severn Trent (SVT) 2,049.00p -1.06%Anglo American (AAL) 1,549.00p -0.48%United Utilities Group (UU.) 784.00p -0.38%Carnival (CCL) 2,229.00p -0.36%Glencore Xstrata (GLEN) 331.75p -0.03%Rio Tinto (RIO) 2,866.50p -0.02%FTSE 250 - RisersNew World Resources A Shares (NWR) 115.20p +8.88%Victrex (VCT) 1,720.00p +5.65%Pace (PIC) 260.00p +4.00%Ferrexpo (FXPO) 177.20p +3.99%Telecity Group (TCY) 979.50p +3.93%Laird (LRD) 212.10p +3.87%Inchcape (INCH) 569.50p +3.73%Ashtead Group (AHT) 655.00p +3.39%Spirax-Sarco Engineering (SPX) 2,881.00p +3.37%Homeserve (HSV) 263.60p +3.37%FTSE 250 - FallersHochschild Mining (HOC) 241.30p -2.43%Kazakhmys (KAZ) 318.40p -2.36%AZ Electronic Materials SA (DI) (AZEM) 316.30p -2.23%Kenmare Resources (KMR) 31.00p -2.08%Dunelm Group (DNLM) 854.00p -1.84%EnQuest (ENQ) 131.50p -1.28%Telecom Plus (TEP) 1,271.00p -1.24%Salamander Energy (SMDR) 164.80p -1.20%HICL Infrastructure Company Ltd (HICL) 128.60p -1.08%Carpetright (CPR) 635.00p -1.01%
More News
2 Aug 2023 14:28

GSK sues Pfizer in US for patent infringement over RSV vaccine

Aug 2 (Reuters) - British biopharmaceutical giant GSK sued Pfizer in Delaware federal court on Wednesday, accusing Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo of violating GSK's patent rights in its rival RSV shot Arexvy.

Read more
2 Aug 2023 10:41

Sensodyne maker Haleon's shiny forecast signals price hikes unlikely to dent demand

Shares down 1% on slight decline in H1 adj operating margin

*

Read more
2 Aug 2023 08:23

TOP NEWS: Haleon boosts annual guidance after solid first half

(Alliance News) - Haleon PLC on Wednesday upped its annual organic revenue growth guidance following a solid revenue performance in the first half of 2023.

Read more
31 Jul 2023 19:42

IN BRIEF: GSK hails US FDA approval for cancer treatment, Jemperli

GSK PLC - London-based pharmaceutical company - Jemperli plus chemotherapy approved in the US by the Food & Drug Administration as the first new frontline treatment option in decades for primary advanced or recurrent endometrial cancer. Notes Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy. Hesham Abdullah, senior vice president and global head of oncology development at GSK, says: "Today's approval underscore our belief in the potential for Jemperli to transform cancer treatment as a backbone immuno-oncology therapy."

Read more
31 Jul 2023 12:21

DIRECTOR DEALINGS: Qinetiq, Tesco and GSK executives sell shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced late last week and not separately reported by Alliance News:

Read more
31 Jul 2023 09:16

LONDON BROKER RATINGS: Oddo BHF raises IAG to 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
26 Jul 2023 11:06

GSK raises 2023 outlook boosted by vaccine, HIV drug sales

Q2 sales and earnings beat estimates

*

Read more
26 Jul 2023 09:28

TOP NEWS: GSK raises annual guidance on quarterly earnings growth

(Alliance News) - GSK PLC on Wednesday upgraded its full-year guidance, after seeing a strong quarterly performance on the strength of segments like HIV and Vaccines.

Read more
26 Jul 2023 07:55

GSK lifts full-year guidance after 'excellent' Q2

(Sharecast News) - GSK lifted its full-year guidance on Wednesday after an "excellent" second quarter.

Read more
24 Jul 2023 08:25

GSK says HIV prevention drug recommended for marketing in Europe

(Alliance News) - GSK PLC on Monday said ViiV Healthcare's cabotegravir for HIV prevention has received a positive opinion by the European Medicines Agency for marketing authorisation.

Read more
24 Jul 2023 07:07

GSK's ViiV gets Europe nod for HIV prophylaxis

(Sharecast News) - Pharmaceuticals giant GSK announced on Monday that its majority-owned HIV specialist subsidiary ViiV Healthcare has received a positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP), recommending marketing authorisation for 'cabotegravir' long-acting (LA) injectable and tablets for HIV prevention.

Read more
22 Jul 2023 18:32

Bavarian Nordic ends RSV vaccine programme after poor trial results

July 22 (Reuters) - Denmark-based Bavarian Nordic said on Saturday it was ending its respiratory syncytial virus (RSV) vaccine programme as its Phase 3 clinical trial did not meet all the primary goals of preventing lower respiratory tract disease.

Read more
14 Jul 2023 09:13

LONDON BROKER RATINGS: HSBC says 'buy' AstraZeneca but 'reduce' GSK

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
14 Jul 2023 07:56

LONDON BRIEFING: Burberry shines in China; ITV-All3Media deal unlikely

(Alliance News) - Stocks in London are expected to slip into the red at Friday's open, in a tepid conclusion to what has been a largely positive week for global equities, as the market prices in a lower peak for US interest rates.

Read more
13 Jul 2023 16:13

Sensodyne toothpaste-maker Haleon planning job cuts - The Guardian

July 13 (Reuters) - Haleon, the world's biggest standalone consumer health business, is planning to cut hundreds of roles in the UK and worldwide, the Guardian reported on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.